These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32471974)

  • 1. Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients.
    Witte HM; Hertel N; Merz H; Bernd HW; Bernard V; Stölting S; von Bubnoff N; Feller AC; Gebauer N
    Blood Cancer J; 2020 May; 10(5):63. PubMed ID: 32471974
    [No Abstract]   [Full Text] [Related]  

  • 2. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
    Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
    Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous regression of a plasmablastic lymphoma with MYC rearrangement.
    Yordanova K; Stilgenbauer S; Bohle RM; Lesan V; Thurner L; Kaddu-Mulindwa D; Bittenbring JT; Scharberger M; Aßmann G; Bewarder M
    Br J Haematol; 2019 Sep; 186(6):e203-e207. PubMed ID: 31257571
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.
    Montes-Moreno S; Martinez-Magunacelaya N; Zecchini-Barrese T; Villambrosía SG; Linares E; Ranchal T; Rodriguez-Pinilla M; Batlle A; Cereceda-Company L; Revert-Arce JB; Almaraz C; Piris MA
    Mod Pathol; 2017 Jan; 30(1):85-94. PubMed ID: 27687004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement.
    Ise M; Kageyama H; Ikebe D; Araki A; Kumagai K; Itami M
    J Clin Exp Hematop; 2018 Sep; 58(3):128-135. PubMed ID: 30012920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmablastic lymphoma: from genetics to treatment.
    Frontzek F; Hailfinger S; Lenz G
    Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
    Meer S; Perner Y; McAlpine ED; Willem P
    Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry.
    Pather S; Mashele T; Willem P; Patel M; Perner Y; Motaung M; Nagiah N; Waja F; Philip V; Lakha A; Hale MJ
    Histopathology; 2021 Jul; 79(1):86-95. PubMed ID: 33450085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV positive mucocutaneous ulcer with plasmacytic/plasmablastic differentiation and MYC rearrangement: a diagnostic challenge and a mimic of plasmablastic lymphoma.
    Chen BJ; Chiang WF; Chen TS; Kao HJ; Chuang SS
    Pathology; 2019 Oct; 51(6):648-650. PubMed ID: 31472984
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report.
    Romero M; González-Fontal GR; Saavedra C; Guerra J; Quintero G; Quijano S; Ney D; Henao-Martínez AF
    Diagn Cytopathol; 2016 Jan; 44(1):61-5. PubMed ID: 26468050
    [No Abstract]   [Full Text] [Related]  

  • 12. KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice.
    Rosean TR; Holman CJ; Tompkins VS; Jing X; Krasowski MD; Rose-John S; Janz S
    Blood Cancer J; 2016 Feb; 6(2):e398. PubMed ID: 26918362
    [No Abstract]   [Full Text] [Related]  

  • 13. SLAMF7 (CD319/CS1) is expressed in plasmablastic lymphoma and is a potential diagnostic marker and therapeutic target.
    Shi J; Bodo J; Zhao X; Durkin L; Goyal T; Meyerson H; Hsi ED
    Br J Haematol; 2019 Apr; 185(1):145-147. PubMed ID: 29785767
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Loghavi S; Gomez Mediavilla A; Tonda R; Beltran S; Gut M; Pereña Gonzalez A; d'Ámore E; Visco C; Khoury JD; Montes-Moreno S
    Haematologica; 2021 Apr; 106(4):1120-1128. PubMed ID: 32273478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic efficacy of low dose lenalidomide as single agent in a patient with refractory gastric non-human immunodeficiency virus-associated plasmablastic lymphoma.
    Carras S; Regny C; Peoc'h M; Gervasoni J; Gressin R; Cahn JY; Molina L
    Leuk Lymphoma; 2015; 56(10):2986-8. PubMed ID: 25676034
    [No Abstract]   [Full Text] [Related]  

  • 16. Incorporating Bortezomib in the Management of Plasmablastic Lymphoma.
    Umeanaeto O; Gamboa J; Diaz J; Hakim MN; Corral J; Philipovskiy A; Gaur S
    Anticancer Res; 2019 Sep; 39(9):5003-5007. PubMed ID: 31519607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmablastic microlymphoma arising in human herpesvirus-8-associated multicentric Castleman disease in a human immunodeficiency virus-seronegative patient with clinical response to anti-interleukin-6 therapy.
    Koenig G; Stevens TM; Peker D
    Histopathology; 2015 Dec; 67(6):930-2. PubMed ID: 25900626
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
    Pretscher D; Kalisch A; Wilhelm M; Birkmann J
    Ann Hematol; 2017 Jun; 96(6):967-970. PubMed ID: 28011983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solitary plasmablastic lymphoma in the esophagus.
    Mihara K; Sasaki N; Mamoru O; Kanbe M; Ichinohe T; Suehiro S
    Ann Hematol; 2016 Apr; 95(5):845-6. PubMed ID: 26925582
    [No Abstract]   [Full Text] [Related]  

  • 20. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.